We work collaboratively to discover and deliver transformative treatments that significantly improve the lives of people living with chronic progressive diseases, especially those of the immune system.
We are discovering new ways to optimize outcomes for a range of chronic progressive diseases by pursuing novel pathways that modulate the immune system in more targeted manners than traditional immunosuppressants.
For immune disorders, we develop approaches that target the innate and adaptive components of the immune system. This includes inhibiting the inappropriate immune activation that contributes to the disorder, as well as inducing immune tolerance, which trains the body not to react to triggers.
To continue discovering and delivering best-in-class therapies for patients, we believe it is crucial to pair our diverse internal expertise with strategic external partnerships.
- This strategy has enabled us to work alongside leading academic institutions and innovative companies to pursue research in new areas and uncover potential therapies.
- Together, we can achieve our goals faster and smarter, to ultimately create a future where patients with chronic progressive diseases can live disease-free.